The NEWTON bioluminescence imaging system allows for the non-invasive detection and quantification from the onset throughout full development of any tumor.
Demonstration of viral clearance targeting latent infectious reservoirs in HIV-1 infected CD34+ human immune system mice treated with LASER ART and CRISPR-Cas9 is available.
